Home › NDC Lookup › RxCUI directory › RxCUI 1665005

Ceftriaxone 500 MG Injection — RxCUI 1665005

RxNorm drug concept · Semantic clinical drug
RxCUI 1665005 Semantic clinical drug · SCD ● Current RxNorm concept 35 FDA products 46 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1665005
Official nameCeftriaxone 500 MG Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asceftriaxone 500 MG (as ceftriaxone sodium) Injection
FDA products mapped35
Package NDCs mapped46
Reported Medicaid activity (SDUD)778,396 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Ceftriaxone Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It is an antibiotic for bacterial infections such as pneumonia, urinary tract infections, skin, bone and joint infections, gonorrhea and meningitis. It is also sometimes given befo...
  • A healthcare professional gives it either through an IV over about 30 minutes or as an injection into a large muscle. How often and how long depends on your infection, so follow yo...
  • Most people tolerate it well. You may notice pain, firmness or tenderness where it was given, vein irritation, or diarrhea. Call your doctor if diarrhea is severe or lingers.
  • Tell your care team first. Some people allergic to penicillin can also react to ceftriaxone, so it must be used with caution. If you have a reaction such as trouble breathing or sw...
📖 Read our full Ceftriaxone Injection guide →

🕸️ Concept Web — How Ceftriaxone 500 MG Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Ceftriaxone 500 MG Injection RxCUI 1665005

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Ceftriaxone 2193
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Ceftriaxone Injection 1664992
    • Ceftriaxone Injectable Product 1152108
    • Injection 1649574
    • Injectable Product 1151126
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Ceftriaxone 500 MG 1665004

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Ceftriaxone 500 MG SCDC · 1665004
  • Ceftriaxone Injection SCDF · 1664992
  • Ceftriaxone Injectable Product SCDG · 1152108

📦 FDA Products & Package NDCs

35 products · 46 package NDCs
46 package NDCs map to RxCUI 1665005 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00143-9856-25 25 VIAL in 1 BOX (0143-9856-25) / 1 INJECTION, POWDER, FOR... Ceftriaxone Hikma Pharmaceuticals USA Inc. 2008-01-10
00143-9857-25 25 VIAL in 1 BOX (0143-9857-25) / 1 INJECTION, POWDER, FOR... Ceftriaxone Hikma Pharmaceuticals USA Inc. 2008-01-10
00143-9858-25 25 VIAL in 1 BOX (0143-9858-25) / 1 INJECTION, POWDER, FOR... Ceftriaxone Hikma Pharmaceuticals USA Inc. 2008-01-10
00143-9859-25 25 VIAL in 1 BOX (0143-9859-25) / 1 INJECTION, POWDER, FOR... Ceftriaxone Hikma Pharmaceuticals USA Inc. 2008-01-10
00409-7332-01 10 VIAL, SINGLE-USE in 1 CARTON (0409-7332-01) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2005-05-09
00409-7332-20 10 VIAL, SINGLE-USE in 1 CARTON (0409-7332-20) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2018-03-19
00409-7335-03 10 VIAL, SINGLE-USE in 1 CARTON (0409-7335-03) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2005-05-09
00409-7335-20 10 VIAL, SINGLE-USE in 1 CARTON (0409-7335-20) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2018-03-19
00409-7337-01 10 VIAL, SINGLE-USE in 1 CARTON (0409-7337-01) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2005-05-09
00409-7337-20 10 VIAL, SINGLE-USE in 1 CARTON (0409-7337-20) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2018-03-19
00409-7338-01 10 VIAL, SINGLE-USE in 1 CARTON (0409-7338-01) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2005-05-09
00409-7338-20 10 VIAL, SINGLE-USE in 1 CARTON (0409-7338-20) / 1 INJECTIO... Ceftriaxone Sodium Hospira, Inc 2018-03-19
00781-3206-85 1 VIAL, SINGLE-USE in 1 CARTON (0781-3206-85) / 1 INJECTION... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3206-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3206-95) / 1 INJECTIO... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3207-85 1 VIAL, SINGLE-USE in 1 CARTON (0781-3207-85) / 1 INJECTION... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3207-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3207-95) / 1 INJECTIO... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3208-85 1 VIAL, SINGLE-USE in 1 CARTON (0781-3208-85) / 1 INJECTION... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3208-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3208-95) / 1 INJECTIO... Ceftriaxone Sodium Sandoz Inc 2005-05-09
00781-3209-95 10 VIAL, SINGLE-USE in 1 CARTON (0781-3209-95) / 1 INJECTIO... Ceftriaxone Sodium Sandoz Inc 2005-05-09
25021-0106-10 25 VIAL in 1 CARTON (25021-106-10) / 1 INJECTION, POWDER, F... ceftriaxone Sagent Pharmaceuticals 2009-11-05
25021-0107-20 25 VIAL in 1 CARTON (25021-107-20) / 1 INJECTION, POWDER, F... ceftriaxone Sagent Pharmaceuticals 2009-11-05
44567-0700-25 25 VIAL in 1 CARTON (44567-700-25) / 1 INJECTION, POWDER, F... Ceftriaxone WG Critical Care, LLC 2008-07-24
44567-0701-25 25 VIAL in 1 CARTON (44567-701-25) / 1 INJECTION, POWDER, F... Ceftriaxone WG Critical Care, LLC 2008-07-24
44567-0702-25 25 VIAL in 1 CARTON (44567-702-25) / 1 INJECTION, POWDER, F... Ceftriaxone WG Critical Care, LLC 2008-07-24
50090-0944-00 10 VIAL, SINGLE-USE in 1 CARTON (50090-0944-0) / 1 INJECTIO... Ceftriaxone Sodium A-S Medication Solutions 2014-11-28
50090-3838-00 1 VIAL, SINGLE-USE in 1 CARTON (50090-3838-0) / 1 INJECTION... Ceftriaxone Sodium A-S Medication Solutions 2018-11-15
60505-6148-00 1 VIAL, SINGLE-USE in 1 CARTON (60505-6148-0) / 1 INJECTION... Ceftriaxone Sodium Apotex Corp. 2020-03-03
60505-6148-04 10 VIAL, SINGLE-USE in 1 CARTON (60505-6148-4) / 1 INJECTIO... Ceftriaxone Sodium Apotex Corp. 2017-06-30
60505-6149-04 10 VIAL, SINGLE-USE in 1 CARTON (60505-6149-4) / 1 INJECTIO... Ceftriaxone Sodium Apotex Corp. 2017-06-30
60505-6151-01 10 VIAL, SINGLE-USE in 1 CARTON (60505-6151-1) / 1 INJECTIO... Ceftriaxone Sodium Apotex Corp. 2017-06-30
60505-6151-04 1 VIAL, SINGLE-USE in 1 CARTON (60505-6151-4) / 1 INJECTION... Ceftriaxone Sodium Apotex Corp. 2017-06-30
60505-6152-01 10 VIAL, SINGLE-USE in 1 CARTON (60505-6152-1) / 1 INJECTIO... Ceftriaxone Sodium Apotex Corp. 2017-06-30
60505-6152-04 1 VIAL, SINGLE-USE in 1 CARTON (60505-6152-4) / 1 INJECTION... Ceftriaxone Sodium Apotex Corp. 2017-06-30
63323-0346-10 25 VIAL in 1 CARTON (63323-346-10) / 1 INJECTION, POWDER, F... Ceftriaxone Fresenius Kabi USA, LLC 2011-06-20
67184-1005-01 10 VIAL, SINGLE-USE in 1 CARTON (67184-1005-1) / 1 INJECTIO... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
67184-1005-02 1 VIAL, SINGLE-USE in 1 CARTON (67184-1005-2) / 1 INJECTION... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
67184-1006-01 10 VIAL, SINGLE-USE in 1 CARTON (67184-1006-1) / 1 INJECTIO... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
67184-1006-02 1 VIAL, SINGLE-USE in 1 CARTON (67184-1006-2) / 1 INJECTION... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
67184-1007-01 10 VIAL, SINGLE-USE in 1 CARTON (67184-1007-1) / 1 INJECTIO... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
67184-1008-01 10 VIAL, SINGLE-USE in 1 CARTON (67184-1008-1) / 1 INJECTIO... Ceftriaxone Sodium Qilu Pharmaceutical Co., Ltd. 2016-06-29
76420-0596-01 1 VIAL, SINGLE-USE in 1 CARTON (76420-596-01) / 1 INJECTION... Ceftriaxone Sodium Asclemed USA, Inc. 2023-09-02
76420-0596-10 10 VIAL, SINGLE-USE in 1 CARTON (76420-596-10) / 1 INJECTIO... Ceftriaxone Sodium Asclemed USA, Inc. 2023-09-02
82804-0066-01 1 VIAL, SINGLE-USE in 1 CARTON (82804-066-01) / 1 INJECTION... Ceftriaxone Sodium Proficient Rx LP 2024-02-02
82804-0066-10 10 VIAL, SINGLE-USE in 1 CARTON (82804-066-10) / 1 INJECTIO... Ceftriaxone Sodium Proficient Rx LP 2024-02-02
85766-0128-01 1 VIAL, SINGLE-USE in 1 CARTON (85766-128-01) / 1 INJECTION... Ceftriaxone Sodium Sportpharm LLC 2025-12-03
85766-0128-10 10 VIAL, SINGLE-USE in 1 CARTON (85766-128-10) / 1 INJECTIO... Ceftriaxone Sodium Sportpharm LLC 2025-12-03
Observed labelers: Hospira, Inc (8) · Apotex Corp. (7) · Sandoz Inc (7) · Qilu Pharmaceutical Co., Ltd. (6) · Hikma Pharmaceuticals USA Inc. (4) · WG Critical Care, LLC (3) · +6 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J0696 Ceftriaxone sodium injection 33 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.